Loading stock data…
InfuSystems Holdings, Inc. (INFU)
$11.89-0.35 (-2.86%)
Market ClosedLast close Sep 8
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
InfuSystem Holdings, Inc. in the Healthcare sector is trading at $11.89 with a market capitalization of $238M. Wall Street consensus targets $16.83 (3 analysts), implying a +41.6% move over the next 12 months. The stock is currently near its 52-week high of $12.97, remaining 24.8% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +41.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 35) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $36.93M↑ | $33.68M↓ | $36.23M↓ | $36.49M↑ | $36.00M |
| Gross Profit | $21.41M↑ | $19.68M↓ | $20.43M↓ | $20.82M↑ | $19.87M |
| Operating Income | $4.15M↑ | $1.59M↓ | $3.71M↓ | $3.81M↑ | $3.78M |
| Net Income | $3.23M↑ | $1.02M↓ | $2.04M↓ | $2.26M↓ | $2.60M |
Peer Comparison
JNJUNHPFE
Fundamentals
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$238.01M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
29.88
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.46
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
14.44%
Volume
Today's trading volume
104,650
Recent News
Unique Payer Network Strengthens InfuSystem (INFU)
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here. The strategy returned 24.01% in the second quarter, outperforming the Russell 2000 Index’s 21.49% return. Performance was positively affected by stock selection in health care and industrials, while the Fund’s underweight position […]
InfuSystem (INFU) Q2 2026 Earnings Call Transcript
Patient Services surged 15% as Wound Care revenue nearly tripled.
InfuSystem Holdings, Inc. Q2 2026 Earnings Call Summary
Moby summary of InfuSystem Holdings, Inc.'s Q2 2026 earnings call
InfuSystems Holdings Inc (INFU) (Q2 2026) Earnings Call Highlights: Record Revenue and Oncology ...
InfuSystems posts record Q2 revenue of $36.9M, with oncology surpassing $20M and wound care surging 154%, while navigating GE contract restructuring.
InfuSystems Holdings, Inc. (INFU) Q2 Earnings and Revenues Surpass Estimates
InfuSystems Holdings (INFU) delivered earnings and revenue surprises of +25.00% and +1.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?